$3.780
-0.261 (-6.90%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
AQST Prediction & Forecast by Similar Chart Analysis
Alphio's AQST stock price prediction model matches the current Aquestive Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.74 (-1.16%). The 1-week path is $3.91 (+3.47%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Aquestive Therapeutics, Inc. Stock?
Currently, Aquestive Therapeutics Inc (AQST) is not a good buy. The stock is trading at $3.78, which is significantly below the analyst price target of $8, indicating potential upside. However, the stock has a very low RSI of 12.312, suggesting it is oversold, but this is accompanied by a concerning trend with a 5-day change of -20.92% and a year-to-date change of -41.40%. The recent insider selling has increased by 140.84%, which raises concerns about insider confidence in the company's future. The main risk is the negative net income, which was -22.9 million in Q2 2026, indicating ongoing financial struggles.
AQST stock price ended at $3.78 on Friday, after losing -6.90%
Aquestive Therapeutics, Inc. (AQST) last closed at $3.78, losing -6.90%. These facts feed the 1-day and 1-week AQST price prediction above.
Analyst Consensus
Aquestive Therapeutics, Inc. (AQST): 4 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Aquestive Therapeutics, Inc. (AQST) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches AQST, ranked by similarity.
Seasonality analysis for AQST
Historically the probability of a positive October return for AQST is 79.31%. November offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for AQST
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $1.65 | $2.12 | $2.20 | -44.05% |
| Nov 2026 | $1.91 | $2.12 | $2.51 | -44.05% |
| Dec 2026 | $2.43 | $2.61 | $2.66 | -31.08% |
In 2026, Aquestive Therapeutics, Inc. (AQST) is projected to range from $1.65 to $2.66.
Aquestive Therapeutics, Inc. 2026 monthly forecast
In Oct 2026, Aquestive Therapeutics, Inc. is projected to average $2.12, with a low of $1.65 and high of $2.20.
In Nov 2026, Aquestive Therapeutics, Inc. is projected to average $2.12, with a low of $1.91 and high of $2.51.
In Dec 2026, Aquestive Therapeutics, Inc. is projected to average $2.61, with a low of $2.43 and high of $2.66.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.